Ccnd1
|
-3.1 |
0.019304 |
PI3K/AKT pathway [27] |
Cd14
|
-2.1 |
0.00953 |
TLR response [28] |
Cd80
|
4.7 |
0.03 |
Macrophage polarization marker [8, 29] |
Cd86
|
4.3 |
0.02 |
Macrophage polarization marker[8, 29] |
Eif2ak2
|
-2.3 |
0.006488 |
NF-κB pathway [30] |
Elk1
|
-7.3 |
0.000049 |
TLR response [31] and cancer development [32] |
Flt3l
|
-4.1 |
0.00104 |
PI3K/AKT pathway [33] |
Fos
|
-5.9 |
0.00083 |
Cancer development [34] |
Gdf1
|
-2.7 |
7E-06 |
TGF-beta super-family [35] |
Il10
|
-6.0 |
0.03872 |
Anti-inflammatory cytokine [36]. |
Il1b
|
-6.2 |
0.050638 |
Inflammatory cytokine [37, 38] |
Il1f9
|
-27.5 |
0.03639 |
Inflammatory cytokine [39] |
Il1rn
|
-4.2 |
0.00048 |
IL-1 pathway [40] |
Map2k1
|
-3.3 |
0.032279 |
MAPK pathway [41] |
Mapk14
|
-4.1 |
0.014773 |
MAPK pathway [42] |
Mcr
|
-2.5 |
0.04 |
Macrophage polarization marker[8, 29] |
Mtcp1
|
-7.9 |
0.000981 |
Increase activation of AKT1 and AKT2 [43] |
Naip1
|
6.3 |
0.032882 |
Anti-apoptotic [44] |
Nfkb1
|
-5.8 |
0.05567 |
NF-κB pathway [45] |
Pak1
|
-17.3 |
0.032134 |
MAPK pathway [46] |
Pdk1
|
-5.6 |
0.031172 |
NO pathway [47] |
Pik3ca
|
-2.1 |
0.024495 |
PI3K/AKT pathway[48] and involved in cancer [49] |
Pik3cg
|
-2.7 |
0.008274 |
PI3K/AKT pathway and TLR response [50] |
Pik3r2
|
-2.6 |
0.020004 |
PI3K/AKT pathway [48] |
Prkca
|
-4.7 |
0.000282 |
MAPK pathway [51] |
Rps6ka1
|
-2.2 |
0.017273 |
MAPK pathway [52] |
Srf
|
-4.8 |
0.038967 |
MAPK pathway [53] |
Tirap
|
-47.9 |
0.022142 |
TLR response [54] |
Tlr4
|
-3.6 |
0.018578 |
TLR response [55] |
Tnfsf12
|
-2.6 |
0.00383 |
TNF-α cascade [56] |